Literature DB >> 21235913

Reactive oxygen species as mediators of signal transduction in cardiovascular disease.

J Abe, B C Berk.   

Abstract

Reduction-oxidation (redox) reactions that generate reactive oxygen species (ROS) have been identified as important chemical processes that regulate signal transduction. Because increased ROS may be a risk factor for cardiovascular events such as unstable angina, myocardial infarction and sudden death, understanding the biological processes that generate ROS and the intracellular signals elicited by ROS will be important to gain insight into the pathogenesis of these diseases. In this review, we discuss the enzymes that generate ROS in cardiovascular tissues, the role of the mitogen-activated protein (MAP) kinase pathway in redox-sensitive signal transduction, and focus on tyrosine kinases as proximate "sensors" for redox-mediated signal events. The mechanisms by which these kinases regulate gene transcription are then discussed to provide insight into the pathogenic roles of ROS in hypertension, atherosclerosis and vascular remodeling.
Copyright © 1998 Elsevier Science Inc. All rights reserved.

Entities:  

Year:  1998        PMID: 21235913     DOI: 10.1016/S1050-1738(97)00133-3

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  38 in total

Review 1.  Oxidative stress and vascular damage in hypertension.

Authors:  R M Touyz
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

Review 2.  Targeting NADPH oxidases in vascular pharmacology.

Authors:  Agata Schramm; Paweł Matusik; Grzegorz Osmenda; Tomasz J Guzik
Journal:  Vascul Pharmacol       Date:  2012-03-03       Impact factor: 5.773

3.  SOXF: redox mediators of vascular smooth muscle cell growth.

Authors:  Z G Jin; B C Berk
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

4.  Signal transduction mechanisms involved in cardiac preconditioning: role of Ras-GTPase, Ca2+/calmodulin-dependent protein kinase II and epidermal growth factor receptor.

Authors:  Ibrahim F Benter; Jasbir S Juggi; Islam Khan; Mariam H M Yousif; Halit Canatan; Saghir Akhtar
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

5.  Prostate epithelium-specific deletion of the selenocysteine tRNA gene Trsp leads to early onset intraepithelial neoplasia.

Authors:  H Artee Luchman; Michelle L Villemaire; Tarek A Bismar; Bradley A Carlson; Frank R Jirik
Journal:  Am J Pathol       Date:  2014-01-18       Impact factor: 4.307

6.  Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats.

Authors:  Jae Hyung Kim; Lukasz J Bugaj; Young Jun Oh; Trinity J Bivalacqua; Sungwoo Ryoo; Kevin G Soucy; Lakshmi Santhanam; Alanah Webb; Andre Camara; Gautam Sikka; Daniel Nyhan; Artin A Shoukas; Monica Ilies; David W Christianson; Hunter C Champion; Dan E Berkowitz
Journal:  J Appl Physiol (1985)       Date:  2009-08-06

7.  Redox-Dependent Calpain Signaling in Airway and Pulmonary Vascular Remodeling in COPD.

Authors:  Laszlo Kovacs; Yunchao Su
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 8.  The role of angiotensin II in regulating vascular structural and functional changes in hypertension.

Authors:  Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

9.  A new class of natural glycopeptides with sugar moiety-dependent antioxidant activities derived from Ganoderma lucidum fruiting bodies.

Authors:  Yalin Wu; Denong Wang
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

10.  Ebselen attenuates oxidative stress-induced apoptosis via the inhibition of the c-Jun N-terminal kinase and activator protein-1 signalling pathway in PC12 cells.

Authors:  Masanori Yoshizumi; Toshiaki Kogame; Yuki Suzaki; Yoshiko Fujita; Moe Kyaw; Kazuyoshi Kirima; Keisuke Ishizawa; Koichiro Tsuchiya; Shoji Kagami; Toshiaki Tamaki
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.